Organisation paid for research Program year 2023 Source: CMS Open Payments

DCT Genesis LLC

Neither a doctor nor a teaching hospital

Research payments

$1,259,637

612 payments

Through program year 2023, DCT Genesis LLC is reported as receiving $1,259,637 in research payments, across 612 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$7,766	9
2022	Research	$49,067	34
2021	Research	$244,141	148
2020	Research	$216,686	89
2019	Research	$741,977	332

Breakdown

Who paid Research payments · program years 2019–2023

AbbVie, Inc. $1,259,637 612 payments

Studies the money was for Research payments · program years 2019–2023

M16-283 $666,668 298 payments
M14-702 $277,575 112 payments
A Phase 3b Study to Evaluate the Long-Term Safety of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women $111,914 54 payments
A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Estradiol/Norethindrone Acetate in Subjects with Moderate to Severe Endometriosis-Associated Pain $79,110 63 payments
A Phase 3b Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Combined Oral Contraceptives in Premenopausal Women with Documented Endometriosis and Associated Moderate to Severe Pain $60,884 40 payments
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain $49,067 34 payments
M18-969 $13,737 8 payments
M11-352 $574 1 payment
M12-816 $109 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.